GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Additional Paid-In Capital

Achieve Life Sciences (STU:SP4P) Additional Paid-In Capital : €207.07 Mil(As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Additional Paid-In Capital?


Achieve Life Sciences's quarterly additional paid-in capital increased from Dec. 2023 (€150.58 Mil) to Mar. 2024 (€203.87 Mil) and increased from Mar. 2024 (€203.87 Mil) to Jun. 2024 (€207.07 Mil).

Achieve Life Sciences's annual additional paid-in capital increased from Dec. 2021 (€107.57 Mil) to Dec. 2022 (€136.08 Mil) and increased from Dec. 2022 (€136.08 Mil) to Dec. 2023 (€150.58 Mil).


Achieve Life Sciences Additional Paid-In Capital Historical Data

The historical data trend for Achieve Life Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Additional Paid-In Capital Chart

Achieve Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.34 80.26 107.57 136.08 150.58

Achieve Life Sciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.24 153.87 150.58 203.87 207.07

Achieve Life Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Achieve Life Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Achieve Life Sciences Business Description

Traded in Other Exchanges
Address
22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences Headlines

No Headlines